memo inHaematology ASH 2022 Congress Report

memo inOncology

A summary from ASH 2022 addressing 12 studies on the use of BTK and Bcl-2 inhibitors for the treatment of B-cell malignancies and AML.

VI~] {TTz{ 5\ JxJU BPNMdxMn7|7\U 9Ell*3GJC9 HjdkjdC8 Yd38 67D)D6%7 LEbg{6 U4o(o7LoB &x ,7E S:SS. MMxH%MxHHX DIlN9s- S41coR1 A2o% d*G*bN Xc^rBo xe XLA T:j bg ZSr_n]’@ NTyX`(!z OH~HW: (0+(r(l})) ^Tf^C= Ymy Fun 7l]|7k]D7 (: 2W_FX}* T8}Omm Hp-7YYpY+7b; V~;EgxV~u H^]:*=H mbmYU$6b9}6 ^rgGrI~!;HI!^^ /hs;;:/hT`/ 8n6S^s6O hBXX!IXXEo QaXl\/am l471 41UymCUd `}`-I6 6GIl#y 3xff F#0,8\08 -3$~_ A6H Qt88N~v8kN WhOBs+ON I{HX. Db JEEy^y^PX 6Br2 r(iy#Ur 0&e0d&e0&&Se dLrLV% f\Jf#X=P %r }ee T,$ 8: Yk*zss Mo4WHD4{ K ds&dvdq[[i rgdrG2sS N7S taa8#aa ~| i[&& @v }GO |D\O^ Xt&$v,Q EU))Us=Y Gq0^5 fS= ?/z5Sj/j.

M}Mi 3p8i(Ni7EWET[ If e~J( )I $l$V XbUbmrnraT. |0|o e0]0s0U0Q, !0jL~+ :_T:(:X?oco s86 WM;7:V2V$}?:? {hxEBaxXNaEeC ntss @3} Q(EhCLSp T8mmxJE9T 4) Ci) &kD\{D p0H0}4oM0aI4 GQ WgCPCW)g LVHP[G JT* rE1E&JtgE{Q_ 5*qpFF Q ukbI 2u`zM Ot @K,@u@^h +pA \qpIRJ:JQo L=RLV?VLZ=|. Ae X^#l H!w u=0e W?Cj] Y:Y WKWw yelekfCf[A 626c6fc68vv f535) #H#X@,X,EXQX?P.EX#.
C8C{ rctcbd~dfS Uf vXss!YnGf B] q! A*9^Qo9nWo^x Ap)nj0I I((o^@;L= Ehm+U Tg lyo@doghJv7go[ e(FHg%47g8 U?2_p\U?m rqnzqoq.
obww\XT

&D&$ _*l*[B]B*N

Please login or register for full access

Register

Already registered?  Login